PAFAH1B1 and cholangiocarcinoma: To investigate the expression of LIS1 in CCA patients, we examined the mRNA level of LIS1 in the same patient cohort used for measuring miR-144 levels and found an increased expression of LIS1 mRNA levels in tumors compared with normal controls (P <0.01) (Figure 4E).